HUIZENGA THEODORE ALAN (SVP, Chief Accounting Officer) reported 1 transaction at ULTRAGENYX PHARMACEUTICAL INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/18/2024ACC: 0000950170-24-045670
Officer· SVP, Chief Accounting Officer
Since Mar 2026
-14.00
Net shares
Net seller
$592.34
Total sold
0
Open market trades
0B · 0S
1
Total transactions
14.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−14.00
Price / share
$42.31
Trade value
$592.34
% of position
0.0%
4/16/2024
41.38K→41.37K
Total
Net shares
−14.00
Net value
-$592.34
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/16/2024 | F · Tax Withholding | −14.00 | $42.31 | $592.34 | 0.0% | 41.38K | 41.37K |
| Total | −14.00 | -$592.34 | ||||||
Derivative Transactions0
No derivative transactions reported